Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts-Reference-Cited by-同舟云学术

Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts

Published:2009-02 Issue:2 Volume:82 Page:93-105
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Patriarca Francesca,Petrucci Maria T.,Bringhen Sara.,Baldini Luca,Caravita Tommaso,Corradini Paolo,Corso Alessandro,Di Raimondo Francesco,Falcone Antonietta,Ferrara Felicetto,Morabito Fortunato,Musto Pellegrino,Offidani Massimo,Petrini Mario,Rizzi Rita,Semenzato Gianpietro,Tosi Patrizia,Vacca Angelo,Cavo Michele,Boccadoro Mario,Palumbo Antonio

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2008.01179.x/fullpdf

Reference91 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Towards a new age in the treatment of multiple myeloma;Piazza;Ann Hematol,2007

3. Immunomodulatory analogues of thalidomide in the treatment of multiple myeloma;Suppiah;Clin Lymphoma Myeloma,2006

4. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis;Sirohi;Eur J Cancer,2006

5. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group;International Myeloma Working Group;Br J Haematol,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bortezomib enhances G-CSF-induced hematopoietic stem cell mobilization by decreasing CXCL12 levels and increasing vascular permeability;Experimental Hematology;2021-05

2. Safety and comfort of domestic bortezomib injection in real-life experience;Supportive Care in Cancer;2018-03-24

3. Delayed Chemotherapy-induced Nausea and Vomiting in Autologous Hematopoietic Cell Transplant Patients: An Exploratory Analysis;Tumori Journal;2015-11

4. Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma;Expert Opinion on Investigational Drugs;2013-04-04

5. Bortezomib for the treatment of previously untreated multiple myeloma;Immunotherapy;2013-04